Application of Treadmill Exercise Using Mice as a Model for Studying the Influence of Maternal Exercise on Offspring Metabolic Reprogramming

This webinar will give you sufficient understanding to classify new products and technologies containing human tissues or cells and to understand the impact of such products in a portfolio.

During this educational webinar, Dr. Timothy A. Hacker discusses strategies and experimental design of long-term, chronic cardiovascular research in rodents. Specifically, he reviews the use of implantable telemetry, imaging and complimentary technologies for cardiovascular research, highlighting when to adopt one technology versus another and the advantages and limitations of each. He shares best-practices related to data acquisition and analysis, data interpretation and how to prepare data in support of your research hypothesis.

Soft tissue tumors are a broad group of neoplasms that involve the connective tissue of the body. Each year, over 13,000 people in the US are diagnosed with soft tissue sarcomas and over 5,000 people succumb to the malignancy. Because soft tissue sarcomas are very ambiguous and amorphous, many time sarcomas are classified as an uncertain type. Advances in immunohistochemistry, as well as the utility of novel markers such as TFE3, TLE1, MyoD1, and MUC4, have aided pathologists in classifying these soft tissue tumors. This discussion will cover the key facts and statistics about soft tissue tumors and what role IHC plays in these difficult diagnoses.

BIO One-on-One Partnering™ is the most efficient way to do business in the biotech and pharma industry without traveling all over the world. Our system makes it easy to search for and identify potential partners and request meetings with prospective biotech investors and senior business development executives. Did you know that partnering attendees average 13 scheduled BIO One-on-One Partnering meetings at BIO?